Researchers find new piece in Alzheimer's puzzle

Feb 25, 2009

Yale researchers have filled in a missing gap on the molecular road map of Alzheimer's disease. In the Feb. 26 issue of the journal Nature, the Yale team reports that cellular prion proteins trigger the process by which amyloid-beta peptides block brain function in Alzheimer's patients.

"It has been a black box," said Stephen M. Strittmatter, senior author of the study and the Vincent Coates Professor of Neurology and director of Cellular Neuroscience, Neurodegeneration and Repair at the Yale School of Medicine. "We have known that amyloid-beta is bad for the brain, but we have not known exactly how amyloid-beta does bad things to neurons."

After an extensive gene expression analysis, the first step in amyloid-beta damage appears to involve cellular prion proteins. These proteins are normally harmless and exist within all cells, but on rare occasions they change shape and cause notorious prion diseases such as Creutzfeldt- Jacob disease, or its well-known variant, mad cow disease.

When the Yale team searched hundreds of thousands of candidates for potential disease-mediating receptors for the specific amyloid-beta form known to play a role in the development of Alzheimer's disease, the most likely candidate was cellular prion proteins. It seems that amyloid-beta peptides latch onto these cellular prion proteins and precipitate the damage in brain cells.

"They start the cascade that make neurons sick" said Strittmatter, a member of the Kavli Institute for Neuroscience.

Since these cellular prion proteins act at an early stage of disease development, the receptors make a promising target for new Alzheimer's therapies, Strittmatter said.

The study does not suggest that the conversion of cellular prion proteins to an infectious agent occurs in Alzheimer's disease, Strittmatter noted. However, the Nature paper does suggest that the role of usually harmless cellular prion proteins in common neurodegenerative diseases should be studied more rigorously, he said.

Source: Yale University

Explore further: Ebola death toll passes 7,500

add to favorites email to friend print save as pdf

Related Stories

Paleontologist presents origin of life theory

Oct 29, 2013

It has baffled humans for millennia: how did life begin on planet Earth? Now, new research from a Texas Tech University paleontologist suggests it may have rained from the skies and started in the bowels ...

Prions can improve the health of fungal populations

Jun 19, 2012

(Phys.org) -- Prions, infectious agents composed of proteins with a specific misfolded and transmissible 3D structure that cuases diseases like BSE, can be present in fungal populations on a large scale, preventing the spread ...

Recommended for you

Ebola death toll passes 7,500

2 hours ago

More than 7,500 people have now died from the Ebola virus, as the number of cases climbs towards 20,000, the World Health Organization said Monday.

Ebola-infected Italian doctor 'recovering'

3 hours ago

An Italian doctor who contracted Ebola in west Africa is recovering but is still in an isolation unit, the specialist clinic in Rome treating him said Monday.

Restrictions lifted at British bird flu farm

Dec 21, 2014

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

Mercury_01
5 / 5 (1) Feb 25, 2009
Researchers find new piece in Alzheimer's puzzle...-
And then promptly forget where they put it and what they were looking for.
menkaur
not rated yet Feb 26, 2009
Researchers find new piece in Alzheimer's puzzle...-
And then promptly forget where they put it and what they were looking for.

it seems, it's about Alzheimer's....

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.